Emin KAYA, Soykan BİÇİM, Mehmet Ali ERKURT, İrfan KUKU, Ahmet SARICI, İlhami BERBER, Ayşe UYSAL

Convalescent plasma therapy in COVID-19

The coronavirus disease 2019 (COVID‐19) affected many people in a short time and 5-10% of them were severely affected by the disease. A variety of treatment methods have been developed for this rapidly spreading disease and vaccine studies have been initiated. One of these treatment methods is convalescent plasma (CP) therapy which is a passive immunization therapy. CP method is based on the principle of giving the plasma containing the antibodies formed against the pathogen to people who have active disease after they have recovered from the disease which is a very effective but short-term solution until a definitive and permanent treatment (vaccine, drug, etc.) is found in pandemic conditions. Here, we presented the use of CP in the COVID-19 pandemic.

PDF

___

1. Samudrala P K, Kumar P, Choudhary K, et al. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol. 2020;883: 173-375.
2. Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, et al. Emerging treatment strategies for COVID-19 infection. Clin Exp Med. 2021;21:167- 79.
3. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ access date 2th Agust 2021
4. Brown B L and McCullough J. Treatment for emerging viruses: Convalescent plasma and COVID-19. Transfus Apher Sci. 2020;59:102790.
5. Franchini M and Liumbruno G M. Convalescent Plasma for the Treatment of Severe COVID-19. Biologics. 2021;15:31-8.
6. WHO Blood Regulators Network (BRN): Interim Position Paper on blood regulatory response to the evolving outbreak of the 2019 novel coronavirus SARS-CoV-2. http://www.transfusion.ru/2020/04-03-3.pdf access date 2nd August 2021
7. Recommendations for Investigational COVID-19 Convalescent Plasma. https://www.fda.gov/vaccines-blood-biologics/investigational-newdrug-applications-inds-cber-regulated-products/recommendationsinvestigational-covid-19-convalescent-plasma access date 2nd Agust 2021
8. Casadevall A and Pirofski L A. The convalescent sera option for containing COVID-19. J Clin Invest. 2020;130:1545-8.
9. Casadevall A and Scharff M D Return to the past: the case for antibodybased therapies in infectious diseases. Clin Infect Dis. 1995;21:150-61.
10. Cheng Y, Wong R, Soo Y O, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24:44- 6.
11. Joyner M J, Carter R E, Senefeld J W, et al. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021;384:1015- 27.
12. Salazar E, Perez K K, Ashraf M, et al. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma. Am J Pathol. 2020;190:1680-90.
13. Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A 2020;117:9490-6.
14. Shen C, Wang Z, Zhao F, et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. Jama 2020;323:1582-9.
15. Ye M, Fu D, Ren Y, et al. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. J Med Virol. 2020;92:1890-901.
16. Liu S T H, Lin H M, Baine I, et al. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020;26:1708-13.
17. O'Donnell M R, Grinsztejn B, Cummings M J, et al. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021;1;131:e150646.
18. Korper S, Weiss M, Zickler D, et al. High Dose Convalescent Plasma in COVID-19: Results from the Randomized Trial CAPSID. medRxiv. 2021;2021;05:21256192.
19. Klassen S A, Senefeld J W, Johnson P W, et al. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021;96:1262-75.
20. Pappa V, Bouchla A, Terpos E, et al. A Phase II Study on the use of convalescent plasma for the treatment of severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms. 2021;11;9:806.
21. Altuntas F, Ata N, Yigenoglu T N, et al. Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2021;60:102955.
22. Oliveira F A, Nucci M P, Rego G N A, et al. Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results. Einstein (Sao Paulo). 2021;19:eRW6186.
23. Erkurt M A, Sarici A, Berber I, et al. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia. Transfus Apher Sci. 2020;59:102867.
24. Akay Cizmecioglu H, Goktepe MH, Demircioglu S, et al. Efficacy of convalescent plasma therapy in severe COVID-19 patients. Transfus Apher Sci. 2021;60:103158.
25. Casadevall A, Dragotakes Q, Johnson P W, et al. Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives? medRxiv. 2021;2021.04.07.21255089.
26. González SE, Regairaz LR. Salazar M, et al. Timing of convalescent plasma administration and 28-day mortality for COVID-19 pneumonia. medRxiv 2021;02.02.21250758.
27. Libster R, Pérez Marc G, Wappner D, et al. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N Engl J Med. 2021;384:610- 8.
28. Desai A, Sachdeva S, Parekh T, et al. COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. JCO Glob Oncol. 2020;6:557-9.
29. Tremblay D, Seah C, Schneider T, et al. Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients. Cancer Med. 2020;9:8571-8.
30. Aries J A, Davies J K, Auer R L, et al. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients. Br J Haematol. 2020;190:64-7.
31. Thompson M A, Henderson J P, Shah P K, et al. Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19. medRxiv 2021;2021.02.05.21250953.
32. Senefeld J W, Klassen S A, Ford S K, et al. Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency. medRxiv 2020;2020.11.08.20224790.
33. Rahman F, Liu S T H, Taimur S, et al. Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City. Clin Transplant. 2020;34:e14089.
34. Yoon H A, Bartash R, Gendlina I, et al. Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC. JCI Insight. 2021;22;6:142270.
35. Avendaño-Solà C, Ramos-Martínez A, Muñez-Rubio E, et al. Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial. medRxiv. 2020;2020.08.26.20182444.